Session Tracks

This session will explore the intricate signaling pathways that govern immunometabolic interactions. Researchers will present their findings on how these pathways influence immune responses and metabolic regulation.

This track focuses on the role of metabolic inflammation in the pathogenesis of various diseases. Presentations will highlight the mechanisms by which inflammation intersects with metabolic disorders.

This session will delve into the metabolic processes that regulate immune cell function in both healthy and diseased states. Participants will discuss how alterations in immune cell metabolism can impact overall health.

This track will examine innovative therapeutic strategies targeting immunometabolic disorders. Experts will share insights into the development and application of immunotherapies aimed at metabolic regulation.

This session will investigate how metabolic pathways influence immune responses during health and disease. Researchers will present data on the interplay between metabolism and immune activation.

This track will explore the impact of gut microbiota on immunometabolic health. Presentations will focus on how microbial communities can modulate immune responses and metabolic processes.

This session will address the relationship between immunometabolism and cancer progression. Researchers will discuss how metabolic alterations in immune cells can influence tumor microenvironments and therapeutic outcomes.

This track will focus on the metabolic pathways that contribute to the development of autoimmune diseases. Presentations will highlight how immune metabolism can be targeted for therapeutic intervention.

This session will examine the connections between chronic inflammation and metabolic syndrome. Researchers will present findings on how inflammatory mediators can drive metabolic dysregulation.

This track will showcase recent advancements in immunotherapeutic approaches for treating metabolic disorders. Experts will discuss the efficacy and mechanisms of these novel therapies.

This session will highlight the discovery and validation of emerging biomarkers in immunometabolic disorders. Researchers will present data on how these biomarkers can enhance diagnosis and treatment strategies.